MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 116 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,413,020 | +19.6% | 241,302 | +48.7% | 0.00% | – |
| Q2 2023 | $2,017,526 | -61.9% | 162,311 | -57.0% | 0.00% | -100.0% |
| Q1 2023 | $5,293,721 | -61.8% | 377,853 | -60.9% | 0.00% | -66.7% |
| Q4 2022 | $13,842,006 | +42.9% | 967,296 | +154.9% | 0.00% | +50.0% |
| Q3 2022 | $9,689,000 | +4.8% | 379,551 | +16.7% | 0.00% | 0.0% |
| Q2 2022 | $9,241,000 | -7.6% | 325,274 | +14.8% | 0.00% | 0.0% |
| Q1 2022 | $9,996,000 | -24.3% | 283,428 | -10.1% | 0.00% | -33.3% |
| Q4 2021 | $13,211,000 | +124.6% | 315,299 | +163.1% | 0.00% | +200.0% |
| Q3 2021 | $5,883,000 | +2.9% | 119,860 | -12.5% | 0.00% | 0.0% |
| Q2 2021 | $5,718,000 | +23.2% | 137,028 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $4,641,000 | +91.1% | 130,228 | +50.4% | 0.00% | 0.0% |
| Q4 2020 | $2,428,000 | – | 86,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |